image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Essentra - £200m borrowing facility available for potential acquisitions

December 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ESNT
  • Price:
  • 779p
It's a truism in investing that the most dull sounding businesses often make the best returns and Essentra (formerly Filtrona), which makes and distributes millions of small but essential components made from plastic, fibre and foam, is a member of this happy club. In its update covering the period from 1 July to 14 October, year on year revenues soared a mighty 23%, of which the like-for-like element was 9%. All areas galloped ahead with the largest division, components and protection, which supplies items such as plugs, threads and fasteners, increasing sales 9%. Porous technologies (components regulating liquids in ink reservoirs) grew 7% and filter products, the legacy cigarette filters business, 15%. Meanwhile, its pac ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author